Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-63100-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2009English

Risk of Contralateral Breast Cancer in Women With and Without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women With Very Early-Onset (<36 Years) Breast Cancer

Cancers
Cancer ResearchOncology
2020English

Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women Under the Age of 50 Years

Breast Cancer Research
Cancer ResearchOncology
2019English

Identification and Characterization of BRCA1 and BRCA2 Founder Mutations

Current Women's Health Reviews
GynecologyObstetrics
2012English

Analysis of the Pathogenic Variants of BRCA1 and BRCA2 Using Next-Generation Sequencing in Women With Familial Breast Cancer: A Case–control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

BRCA1 and BRCA2 Mutations and Clinical Interpretation in 398 Ovarian Cancer Patients: Comparison With Breast Cancer Variants in a Similar Population

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy